Genetic and Clinical Characteristics of Thalassemia Trait and Construction of LASSO‐Based Model for Its Differentiating From Iron Deficiency Anemia in Northern China
4 affiliations
- 1Department of Clinical Laboratory Peking University People's Hospital Beijing China
- 2Department of Clinical Laboratory Tangshan Workers' Hospital Tangshan Hebei China
- 3Department of Clinical Laboratory Sanmenxia Central Hospital Sanmenxia Henan China
- 4Department of Clinical Laboratory Qingdao Chengyang District People's Hospital Qingdao Shandong China
Abstract
Background: Thalassemia trait (TT) and iron deficiency anemia (IDA) represent the most common causes of microcytic hypochromic anemia (MHA) and are challenging to differentiate in clinical settings. Data regarding the genetic and clinical characteristics of TT in Northern China remain insufficient, highlighting an urgent need for rapid and efficient diagnostic strategies for the regional population.
Methods: This retrospective study enrolled 482 TT and 640 IDA patients from Northern China. Twenty‐seven α‐ and β‐TT mutations were detected by multicolor probe melting curve analysis (MMCA) and further confirmed by Sanger sequencing. A LASSO regression model using routine hematological indices was constructed and further validated. The diagnostic efficacy was compared with other indices (Mentzer, Shine and Lal, and Green and King indices).
Results: A total of 482 cases with TT mutations were identified. β‐TT mutations were the most prevalent (n = 261, 54.15%), followed by α‐TT mutations (n = 209, 43.36%) and α+β complex TT mutations (n = 12, 2.49%). Among which, eight α‐TT genotypes, eleven β‐TT genotypes, and eight α+β compound genotypes mutations were detected. For α‐TT, the predominant genotype was _α
SEA
/αα (77.0%), followed by _α
3.7
/αα (14.3%), α
SEA
/_α
3.7 (3.3%) and the rare HKαα (1.0%). The three most prevalent genotypes among β‐TT mutations were HBB:c.316_197C>T heterozygous (het) (35.2%), HBB:c.124_127delTTCT het (29.5%), and HBB:c.52A>T het (23.4%). α‐TT minor (33.82%) and β‐TT minor (53.94%) contributed the predominant phenotypes. The LASSO‐nomogram based on RBC, MCV, MCHC, and RDW‐SD achieved favorable discriminative performance (AUC = 0.94, sensitivity = 90.0%, specificity = 91.8%), showing superior diagnostic efficacy than other indices.
Conclusion: Our study revealed a distinct β‐TT‐dominant genotypic profile in Northern China and provided a simple, region‐adapted model as a potential tool for differentiating TT from IDA in clinical practice.
Related
- Clinical characteristics and treatment analysis of children with glucose transporter type 1 deficiency syndrome: a report of two cases
- Fructose-1,6-bisphosphatase deficiency: the clinical characteristics, molecular consequences of FBP1 variants, and emerging non-canonical functions of FBP1
- Prevalence and clinical significance of α-globin gene subtypes in prenatal thalassemia screening: a focus on the -α3.7III variant in Sanya, Hainan, China
- Clinical utility of CT-based deep learning for differentiating pulmonary aspergillosis from bacterial pneumonia: a multicenter retrospective study
- Single-molecule real-time (SMRT) sequencing technology shows advantages in the clinical diagnosis of complex thalassemia
BibTeX
@article{yu2026genetic,
title = {{Genetic and Clinical Characteristics of Thalassemia Trait and Construction of LASSO‐Based Model for Its Differentiating From Iron Deficiency Anemia in Northern China}},
author = {Wen‐jie Yu and Feng‐qi Zhang and Jia‐feng Niu and Rui Ma and Yin‐ting Ma and Guang‐ping Li and Yan Long},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
month = oct,
doi = {10.1002/jcla.70386},
url = {https://doi.org/10.1002/jcla.70386},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genetic and Clinical Characteristics of Thalassemia Trait and Construction of LASSO‐Based Model for Its Differentiating From Iron Deficiency Anemia in Northern China
AU - Wen‐jie Yu
AU - Feng‐qi Zhang
AU - Jia‐feng Niu
AU - Rui Ma
AU - Yin‐ting Ma
AU - Guang‐ping Li
AU - Yan Long
PY - 2026
DA - 2026/10/26
JO - Journal of Clinical Laboratory Analysis
DO - 10.1002/jcla.70386
UR - https://doi.org/10.1002/jcla.70386
AB - Background: Thalassemia trait (TT) and iron deficiency anemia (IDA) represent the most common causes of microcytic hypochromic anemia (MHA) and are challenging to differentiate in clinical settings. Data regarding the genetic and clinical characteristics of TT in Northern China remain insufficient, highlighting an urgent need for rapid and efficient diagnostic strategies for the regional population. Methods: This retrospective study enrolled 482 TT and 640 IDA patients from Northern China. Twenty‐seven α‐ and β‐TT mutations were detected by multicolor probe melting curve analysis (MMCA) and further confirmed by Sanger sequencing. A LASSO regression model using routine hematological indices was constructed and further validated. The diagnostic efficacy was compared with other indices (Mentzer, Shine and Lal, and Green and King indices). Results: A total of 482 cases with TT mutations were identified. β‐TT mutations were the most prevalent (n = 261, 54.15%), followed by α‐TT mutations (n = 209, 43.36%) and α+β complex TT mutations (n = 12, 2.49%). Among which, eight α‐TT genotypes, eleven β‐TT genotypes, and eight α+β compound genotypes mutations were detected. For α‐TT, the predominant genotype was _α SEA /αα (77.0%), followed by _α 3.7 /αα (14.3%), α SEA /_α 3.7 (3.3%) and the rare HKαα (1.0%). The three most prevalent genotypes among β‐TT mutations were HBB:c.316_197C>T heterozygous (het) (35.2%), HBB:c.124_127delTTCT het (29.5%), and HBB:c.52A>T het (23.4%). α‐TT minor (33.82%) and β‐TT minor (53.94%) contributed the predominant phenotypes. The LASSO‐nomogram based on RBC, MCV, MCHC, and RDW‐SD achieved favorable discriminative performance (AUC = 0.94, sensitivity = 90.0%, specificity = 91.8%), showing superior diagnostic efficacy than other indices. Conclusion: Our study revealed a distinct β‐TT‐dominant genotypic profile in Northern China and provided a simple, region‐adapted model as a potential tool for differentiating TT from IDA in clinical practice.
SN - 0887-8013
SN - 1098-2825
ER -